earnings
confidence high
sentiment positive
materiality 0.75
AtriCure reports preliminary Q4 revenue $140.5M (+13%), FY 2025 $534.5M (+15%); guides 2026 revenue ~$600-610M
AtriCure, Inc.
2025-FY EPS reported
-$0.24
revenue$534,528,000
- Q4 2025 revenue $140.5M (+13% YoY); US $114.3M (+13%), intl $26.2M (+15% as reported).
- FY 2025 revenue $534.5M (+15% YoY); adj. EBITDA $57-59M; adj. loss per share $0.18-0.21.
- Ended 2025 with $167M cash; expects positive cash flow and net income in 2026.
- 2026 revenue guidance $600-610M (+12-14%); adj. EBITDA $80-82M.
- Amended credit facility extended 3 years, reduced interest rate, removed minimum utilization covenant.